Literature DB >> 33167235

Tricolor imaging of MMPs to investigate the promoting roles of inflammation on invasion and migration of tumor cells.

Wenfei Guo1, Xiaonan Gao1, Renhui Zhan2, Zengteng Zhao1, Kehua Xu3, Bo Tang1.   

Abstract

The expression levels of matrix metalloproteinases (MMPs) are closely related to the degree of inflammation which facilitates tumor cells' invasion and migration. A tricolor fluorescence nanoprobe based on high-fidelity gold-selenium (Au-Se) nanoplatform was designed and constructed for simultaneously imaging matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-7 (MMP-7) and matrix metalloproteinase-9 (MMP-9) to thoroughly investigate the tumor cells' invasion and migration behaviors under inflammation environment. The nanoprobe was assembled by attaching Au NPs with three different peptide substrates respectively labeled with fluorescein isothiocyanate (FITC), 5-carboxytetramethylrhodamine (5-TAMRA) and cyanine 5 (Cy5) via the Au-Se bond. The nanoprobe can specifically respond to MMP-2/7/9, thereby triggering the fluorophores' fluorescence that quenched previously by fluorescence resonance energy transfer (FRET) to realize the MMP-2/7/9's visualization in biological systems. Moreover, as the inflammation stimulated by different concentrations lipopolysaccharide (LPS), the expression of MMP-2/7/9 in SMMC-7721 cells was observed to be significantly enhanced by confocal laser scanning microscope (CLSM) imaging, and inflammation was further proved to intensify SMMC-7721 cells' invasion and migration by transwell invasion and migration experiments. Therefore, the nanoprobe can be used to monitor biomarkers to provide a visual system for the degree of invasion and migration of tumor cells in an inflammatory environment, and also offer a new strategy for the study of the correlation between various active biomacromolecules and specific intracellular pathways in cells.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Au–Se bond; Fluorescence imaging; Inflammation; Invasion; Matrix metalloproteinases; Migration

Mesh:

Substances:

Year:  2020        PMID: 33167235     DOI: 10.1016/j.talanta.2020.121525

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  6 in total

Review 1.  Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer.

Authors:  Tsz-Ying Lau; Hiu-Yee Kwan
Journal:  Mar Drugs       Date:  2022-05-30       Impact factor: 6.085

Review 2.  In Vitro Human Cancer Models for Biomedical Applications.

Authors:  Jane Ru Choi; Gül Kozalak; Ighli di Bari; Quratulain Babar; Zahra Niknam; Yousef Rasmi; Kar Wey Yong
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

Review 3.  Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Authors:  Yunchun Zhao; Xiaoling Zheng; Yongquan Zheng; Yue Chen; Weidong Fei; Fengmei Wang; Caihong Zheng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

4.  MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic.

Authors:  Ann Kristin Barton; Ina-Gabriele Richter; Tanja Ahrens; Roswitha Merle; Abdollah Alalwani; Svenja Lilge; Katrin Purschke; Dirk Barnewitz; Heidrun Gehlen
Journal:  Mediators Inflamm       Date:  2021-01-05       Impact factor: 4.711

5.  A Sulfated Polysaccharide from Red Algae (Gelidium crinale) to Suppress Cells Metastasis and MMP-9 Expression of HT1080 Cells.

Authors:  Haiyan Zheng; Yu Pei; Yuan-Lin He; Yi Liu; Minqi Chen; Pengzhi Hong; Chunxia Zhou; Zhong-Ji Qian
Journal:  Foods       Date:  2022-08-06

6.  Effects of S100 calcium-binding protein A8 (S100A8) and S100 calcium-binding protein A9 (S100A9) on matrix metalloproteinase (MMP) expression in nasopharyngeal carcinoma CNE-2 cells.

Authors:  Wenbing Hu; Zezhang Tao; Qiang Zhou; Deqing Zhao; Lei Gu; Sujin Zhu; Jun Chen
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.